Abstract
Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Mini-Reviews in Medicinal Chemistry
Title: Drug Targeting Strategies in Cancer Treatment: An Overview
Volume: 11 Issue: 1
Author(s): J. L. Arias
Affiliation:
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Abstract: Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Export Options
About this article
Cite this article as:
L. Arias J., Drug Targeting Strategies in Cancer Treatment: An Overview, Mini-Reviews in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/138955711793564024
DOI https://dx.doi.org/10.2174/138955711793564024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Current Pharmaceutical Design Traditional Chinese Medicine - Sea Urchin
Mini-Reviews in Medicinal Chemistry Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia
CNS & Neurological Disorders - Drug Targets Poxvirus Cancer Therapy
Recent Patents on Anti-Infective Drug Discovery Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
Current Medicinal Chemistry Cytokine, Chemokine, and Costimulatory Molecule Modulation to Enhance Efficacy of HIV Vaccines
Current Molecular Medicine A Simple Identification of Novel Carbonyl Reducing Enzymes in the Metabolism of the Tobacco Specific Carcinogen NNK
Drug Metabolism Letters Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Viral Carcinogenesis of Oral Region and Recent Trends in Treatment
Recent Patents on Biomarkers Truncated Lactoferricin Peptide Controls Cervical Cancer Cell Proliferation <i>via</i> lncRNA-NKILA/NF-κB Feedback Loop
Protein & Peptide Letters Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Current Drug Targets Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Production and Preliminary In Vivo Evaluations of a Novel in silico-designed L2-based Potential HPV Vaccine
Current Pharmaceutical Biotechnology Behavioral Decision Research Intervention Reduces Risky Sexual Behavior
Current HIV Research Chest Pain in Children
Current Pediatric Reviews Histone Deacetylase Inhibitors as Potent Modulators of Cellular Contacts
Current Drug Targets Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)
Anti-Cancer Agents in Medicinal Chemistry Role of microRNAs in Gynecological Pathology
Current Medicinal Chemistry The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery